.svg){kind=logo}
.svg){kind=logo}
.svg){kind=logo}
International Research
Overview
TheroGenX operates at the intersection of extracellular matrix science, structural tissue technologies, and emerging cellular research, supporting a global network of research institutions, biotechnology companies, and distribution partners.
Through a vertically integrated platform, TheroGenX develops and supplies high-quality human tissue–derived and extracellular matrix–based materials for research, laboratory, and investigational use. Operations are structured to align with applicable U.S. regulatory frameworks and international standards governing human tissue and related materials.
TheroGenX supports international partners through contract manufacturing, private-label development, and material supply for research and investigational applications, in accordance with applicable regulatory and distribution requirements within each respective market.
As global demand continues to expand across the life sciences and advanced research sectors,
TheroGenX is positioned to deliver consistent, scalable, and scientifically grounded solutions to
partners worldwide.
Global Scientific Foundation
Global research initiatives—ranging from early-stage laboratory studies to advanced translational programs—continue to advance the understanding of how extracellular matrix–based materials interact within complex cellular environments.
The study of cellular systems, including signaling pathways, tissue structure, and structural microenvironments, has evolved over decades of scientific advancement and includes ongoing research in areas such as:
- Extracellular matrix (ECM) structure and function
- Cellular communication and signaling pathways
- Extracellular vesicles, including exosomes
- Tissue microenvironment and structural interaction models
Institutions across North America, Europe, Asia, and the Middle East are actively conducting research in areas including:
- Immune system signaling and regulatory pathways
- Investigational models involving inflammatory and autoimmune conditions
- Neurological and musculoskeletal research
- Soft tissue and structural interface studies
- Extracellular vesicle (exosome) communication and signaling
TheroGenX Research Platform
TheroGenX supports a wide range of scientific and investigational development initiatives through materials centered around:
Extracellular Matrix (ECM) Systems
Structurally derived materials designed for the study of tissue interfaces, physical support environments, and biological architecture.
Cellular Signaling Components
Materials utilized in research exploring cellular communication, structural signaling, and coordination within complex biologic systems.
Extracellular Vesicle & Exosome Research
A rapidly advancing area of global research focused on nanoscale vesicles involved in intercellular communication pathways.
Our platform enables partners to conduct laboratory research, preclinical evaluation, and investigational development using materials prepared with an emphasis on consistency, structure, and standardized characteristics.
Global Partnerships & Distribution
TheroGenX collaborates with:
- International research institutions and academic centers
- Biotechnology and pharmaceutical organizations
- Translational research groups
- Regional and global distribution partners
TheroGenX also supports contract manufacturing and private-label supply for qualified international partners, in accordance with applicable regulatory and import/export requirements.
Our infrastructure is designed to support reliable and scalable supply chains, enabling consistent access to materials across multiple global markets.
We provide partners with:
- Standardized material specifications
- Scalable manufacturing and processing capabilities
- Batch consistency
- Logistics and distribution support for international delivery
Commitment to Scientific Advancement
TheroGenX remains actively engaged in supporting the advancement of extracellular matrix and cellular research through:
- Ongoing collaboration with research institutions
- Monitoring emerging areas such as extracellular vesicle and structural tissue research
- Supporting innovation in biologic materials and structural systems
Our platform is designed to evolve alongside the global scientific community, enabling continued exploration and development in next-generation research technologies.
Regulatory & Use Considerations
Materials supplied by TheroGenX for international distribution are provided for research, laboratory, and investigational use.
TheroGenX works with qualified partners globally and supports manufacturing and supply activities in accordance with applicable tissue regulations, import requirements, and distribution guidelines within each respective country.
Use, handling, and application of materials must comply with all applicable local, regional, and national regulatory requirements within the destination market.
TheroGenX does not promote or support use of its materials outside of applicable regulatory frameworks.
Availability of specific materials and services may vary based on regional regulatory requirements.
Global Partnership Opportunities
TheroGenX welcomes collaboration with qualified organizations seeking:
- High-quality extracellular matrix–based materials
- Scalable and consistent supply
- Contract manufacturing and private-label capabilities
- A scientifically grounded and regulatory-aligned platform
- Long-term global distribution and development partnerships
